Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,360 public trials 3,273 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Active, not recruiting

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

NCT06048133

Conditions
Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +12 more
Locations
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • University of Michigan Health System Ann Arbor, Michigan, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • University of Wisconsin Madison, Wisconsin, United States
View Trial Details
Active, not recruiting

Short RT Versus RCT,Followed by Chemo and Organ Preservation for Interm and High-risk Rectal Cancer Patients

NCT04246684

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • Clincal Center Esslingen Esslingen am Neckar, Baden-Wurttemberg, Germany
  • University Clinic Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • University Clinic Mannheim Mannheim, Baden-Wurttemberg, Germany
  • Clinic Ostlab, Staufenclinic Schwaeb.Gmuend, Mutlangen Mutlangen, Baden-Wurttemberg, Germany
View all 75 locations
View Trial Details
Active, not recruiting

Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group

NCT04230759

Conditions
Anal Cancer, Anal Cancer Stage II, Anal Cancer Stage III, +14 more
Locations
  • Univeritätsklinik für Strahlentherapie-Radioonkologie Graz, Austria
  • Institut für Radioonkologie und Strahlentherapie Darmstadt, Germany
  • Klinik und Poliklinik für Strahlentherapie und Radioonkologie Dresden, Germany
  • Klinik für Strahlenheilkunde, Universitätsklinikum Freiburg Freiburg im Breisgau, Freiburg, Germany
View all 25 locations
View Trial Details
Active, not recruiting

Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study

NCT04550481

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Mount Sinai Hospital New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Active, not recruiting

Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment

NCT03847428

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Mobile, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Costa Mesa, California, United States
View all 217 locations
View Trial Details
Active, not recruiting

A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer

NCT05211323

Conditions
Combined Hepatocellular Carcinoma and Cholangiocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +6 more
Locations
  • Sutter Auburn Faith Hospital Auburn, California, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
  • Palo Alto Medical Foundation-Fremont Fremont, California, United States
  • Memorial Medical Center Modesto, California, United States
View all 37 locations
View Trial Details

Related conditions